open access

Vol 53, No 5 (2019)
Letter to the Editors
Published online: 2019-10-23
Submitted: 2019-10-03
Accepted: 2019-10-14
Get Citation

‘Falling off’ the dopamine wagon

Philip W. Tipton, Ryan J. Uitti, William P. Cheshire
DOI: 10.5603/PJNNS.a2019.0048
·
Pubmed: 31657446
·
Neurol Neurochir Pol 2019;53(5):390-391.

open access

Vol 53, No 5 (2019)
Letter to the Editors
Published online: 2019-10-23
Submitted: 2019-10-03
Accepted: 2019-10-14

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

Parkinson’s disease, fracture, levodopa, neurodegenerative disease

About this article
Title

‘Falling off’ the dopamine wagon

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 53, No 5 (2019)

Pages

390-391

Published online

2019-10-23

DOI

10.5603/PJNNS.a2019.0048

Pubmed

31657446

Bibliographic record

Neurol Neurochir Pol 2019;53(5):390-391.

Keywords

Parkinson’s disease
fracture
levodopa
neurodegenerative disease

Authors

Philip W. Tipton
Ryan J. Uitti
William P. Cheshire

References (9)
  1. Nojszewska M, Potulska-Chromik A, Jamrozik Z, et al. Electrophysiological and clinical assessment of dysautonomia in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP): a comparative study. Neurol Neurochir Pol. 2019; 53(1): 26–33.
  2. van Gerpen JA, Al-Shaikh RH, Tipton PW, et al. Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension. Neurology. 2019; 93(14): e1339–e1347.
  3. Johnell O, Melton LJ, Atkinson EJ, et al. Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing. 1992; 21(1): 32–38.
  4. Genever RW, Downes TW, Medcalf P. Fracture rates in Parkinson's disease compared with age- and gender-matched controls: a retrospective cohort study. Age Ageing. 2005; 34(1): 21–24.
  5. Melton LJ, Leibson CL, Achenbach SJ, et al. Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia. Mov Disord. 2006; 21(9): 1361–1367.
  6. Newmark HL, Newmark J. Vitamin D and Parkinson's disease--a hypothesis. Mov Disord. 2007; 22(4): 461–468.
  7. Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord. 2018; 33(3): 372–390.
  8. Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002; 14(2): 223–36; discussion 222.
  9. Rahman S, Griffin HJ, Quinn NP, et al. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord. 2008; 23(10): 1428–1434.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl